Skip to main content
Premium Trial:

Request an Annual Quote

Caprotec Enters Second Collaboration with Bayer CropScience for Use of CCMS Technology

NEW YORK (GenomeWeb News) – Berlin-based biotech-firm Caprotec Bioanalytics said today that it has entered a research collaboration with Bayer CropScience to identify and study an agrochemical target.

The collaboration will use Caprotec's Capture Compound Mass Spectrometry technology to profile the interactions of Bayer CropScience compounds with the proteome of various biological systems. The agreement builds on a previous collaboration between the two companies begun in December 2011 that similarly used the CCMS technology for analysis of a target of interest.

Caprotec's CCMS technology uses capture compounds to reversibly bind target proteins on the basis of small molecule-protein interactions. The captured proteins are then pulled out and analyzed via mass spectrometry.

Financial and other terms of the agreement were not disclosed.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.